Drugmakers' stocks in Europe and India slipped on Wednesday after U.S. President Donald Trump reiterated plans for a "major" ...

Speaking at the Republican NRCC event, US President Donald Trump said that major tariffs on Pharmaceuticals will be in place ...

Nifty Pharma index sinks over 2% as Indian drugmakers face tariff heat; Gland, Aurobindo, Biocon, Sun Pharma among top losers ...

Continuing his economic onslaught, US President Donald Trump said on Tuesday that Washington is planning to announce a "major ...

Reports indicate that India supplies over 45% of generic and around 15% of biosimilar medicines used in the US.

Nifty Pharma index declined as much as 2.64% on Wednesday compared to 0.56% decline in the benchmark Nifty 50.

Aurobindo Pharma announced that its wholly owned step-down subsidiary, CuraTeQ Biologics s.r.o., has received permission from the European Commission (EC) to market Dyrupeg in the European Union.

Indian pharma companies had surged on Thursday, April 3, after Trump's reciprocal tariff announcements had exempted the ...

Indian pharmaceutical companies are crucial to the U.S. healthcare system, filling four out of every ten prescriptions in ...

The worst-hit company was Gland Pharma, which fell more than 11.4%. Divis Labs and Laurus Labs also saw declines of more than ...

By Kashish Tandon (Reuters) -Indian pharmaceutical stocks fell 4.4% on Friday, wiping out gains from the previous session, ...